Biotechnology, Nanotechnology and Converging Technologies

OECD Working Party on Bio-, Nano- and Converging Tech (BNCT)

Peter Schintlmeister

Peter Schintlmeister   Dipl.-Ing. Peter Schintlmeister, September 1964 - January 2017

The Working Party was deeply saddened and affected by the sudden illness and death of its Chair, Peter Schintlmeister. In addition to being a regular actor in science and technology policy at the OECD, Peter was Senior Counsellor Life Sciences, Health and Bioeconomy at Federal Ministry of Science, Research and Economy in his native Austria. Before his work with BNCT, Peter chaired an OECD Task Force on Industrial Biotechnology.

Peter successful led the BNCT through its earliest days, hosting an important strategic meeting in Vienna and guided the Working Party with an experienced hand, eliciting good ideas in an inclusive fashion. He was a stalwart of OECD efforts in industrial biotechnology for several years, and known throughout Europe for his efforts to promote a sustainable bioeconomy and the work of the OECD in this area.

Anyone who worked with Peter would have been struck by his humanity and also his humour. A fixture at the Vienna opera house, he was a man of sophistication, but also common sense and pragmatism. In 2013 he wrote for European Biotechnology: “The Greek philosopher Heraclitus said that the only constant in life is change - and that aphorism applies to policies as well!”

Responsible Biotechnology, Nanotechnology, and Converging Technologies

On 1 January 2015, the Working Party on Biotechnology (WPB) and the Working Party on Nanotechnology (WPN) merged into the Working Party on Biotechnology, Nanotechnology and Converging Technologies (BNCT).

The BNCT is focused on policy issues in emerging technology fields related to bio, nano and converging technologies. It aims to contribute original policy analysis and messages to the global community, and to make ground-breaking proposals to policy makers.Policy issues of interest to the BNCT range across topics as diverse as research and technological development, innovation and commercialisation, standards and regulations, best practice policy formulation and implementation, ethical, legal and social issues, public engagement, education, skills and training, organisation of research, and measurement and evaluation methods and tools. In particular, the BNCT will advise upon emerging policy issues related to the responsible development of biotechnology, nanotechnology and converging technologies, and assist Member countries in understanding and managing the changing nature of research, development and innovation.

The BNCT’s work programme for the next two years will focus on the following areas:

  • Measurement & Impact
  • Emerging Technologies for Health
  • Bio-Production

Past BNCT Meetings

1st BNCT Meeting (3 days)

(18. - 20. May 2015, Paris)

(access: BNCT only)


BNCT Strategic Meeting

(16. - 17. Sept. 2015, Vienna)

(access: BNCT only)


2nd BNCT Meeting (2 days)

(3. - 4. December 2015, Paris)

(access: BNCT only)


3rd BNCT Meeting (3 days)

(25. - 27. May 2016, Paris)

(access: BNCT only)


4th BNCT Meeting (3 days)

(5. - 7. December 2016, Paris)

(access: BNCT only)


5th BNCT Meeting (2 days)

(11. - 12. May 2017, Paris)

(access: BNCT only)

Latest BNCT News

BNCT attends 2016 Bio Future Forum in Korea

Posted by Steffi Friedrichs on February 14, 2017

The OECD BNCT was represented at the 2016 BioFuture Forum in Korea (7th - 8th November 2016) by Hermann Garden (Health) and Jim Philp (Bioeconomy). 

BNCT at BioFutures Forum Korea

Hermann Garden presented on 'Open and Responsible Innovation', and Jim Philp discussed 'The Bioeconomy, the Challenge of the Century for Policy Makers'.

Hermann at Bio Future Forum KoreaJim at Bio Future Forum Korea

The presentations were followed by a panel discussion (see photo 1 and photo 2).